Prague, 3 December 2025 (PROTEXT) – The longevity market is experiencing a global boom. More and more people are becoming aware of the vast possibilities of today’s modern world, and the desire to reach an advanced age while staying free of major health issues and in good physical condition is growing. What was until recently an area reserved mainly for biohackers and enthusiasts is becoming a serious multidisciplinary business attracting investors, medical and pharmaceutical groups, and luxury wellness brands. According to expert estimates, the global longevity market could reach a value of around USD 1.87 trillion by 2034. Projects that manage to combine clinical credibility, measurable results, and premium services will come out on top. For several years, the technological standard in this field has been set by the Czech group H2 Global Group, specializing in the use of molecular hydrogen in medicine, longevity, beauty, and sports, supported by its subsidiaries H2 Medical Technologies, H2 Pharm, and H2 Longevity Lifestyle.
From “Blue Zones” to a Modern and Innovative Approach to Geriatrics
Today’s concept of longevity builds both on inspiration from so-called “Blue Zones”—regions with a high proportion of long-lived inhabitants—and on modern “geroscience,” which describes aging as a biological process influenced, among other factors, by oxidative stress, chronic inflammation, and mitochondrial dysfunction. According to numerous scientific studies, molecular hydrogen plays a very important role in these mechanisms. Many clinical studies and expert papers indicate that it acts as a selective antioxidant, has anti-inflammatory and mitochondria-protective effects, and in preclinical and clinical studies shows significant potential in cognitive health, neurodegenerative diseases, physical performance, and regeneration. Hydrogen is not a miraculous “elixir of immortality,” but a promising bioactive molecule that fits well into the philosophy of safe, long-term, and measurable support for lifespan and healthspan.
H2 Global Group: A Czech Innovator in Molecular Hydrogen
H2 Global Group, headquartered in the Czech Republic, was founded with the goal of building a complete technological and product ecosystem around molecular hydrogen. The group employs physicians, scientists, and pharmacists, has its own R&D facilities, and works closely with Japanese professor Shigeo Ohta—considered the father and founder of hydrogen biomedicine—who is also a co-owner of the company. The company’s portfolio includes solutions for medicine, neuroscience, beauty and wellness, spas and medical centers, sports teams, and corporate wellness programs.
H2 Medical Technologies and Controlled Hydrogen Therapy
A key role in the group’s MedTech segment is played by its subsidiary H2 Medical Technologies. It develops and manufactures safe and efficient molecular hydrogen generators based on modern SPE/PEM technology, capable of producing ultra-pure hydrogen for safe inhalation in both clinical and home environments. A major milestone is the prototype of the world’s first hydrogen generator with which the company will seek registration as the world’s first hydrogen-based medical device. It will also be used in the first clinical trial in the Czech Republic, approved by the State Institute for Drug Control (SÚKL), involving molecular hydrogen inhalation for individuals with mild cognitive impairment (MCI), a condition that often precedes Alzheimer’s dementia.
This clinical study will begin in early 2026 and aims to evaluate the safety and efficacy of controlled hydrogen therapy in MCI patients. Recruitment is currently underway, and the company is looking for suitable volunteers diagnosed with mild cognitive impairment. Applicants must meet these basic criteria: age 50–80, overall good health, a diagnosis of mild cognitive impairment or mild to moderate dementia, and ideally residence in Ostrava or the surrounding area where the study will take place. Participation does not guarantee any health benefits and should not be considered a substitute for standard treatment. Interested individuals may apply until 23 December 2025 at: david.skoloudik@H2medical.com.
This step elevates the use of molecular hydrogen from a supplementary wellness tool to a serious medical instrument of the near future, with potential not only in cognitive health and dementia prevention. This study follows the European patent EP3701956B1 “Prophylactic or Therapeutic Agent for Dementia,” authored by Professor Ohta and held by H2 Global Group. The patent describes the use of molecular hydrogen in neurodegenerative conditions including dementias and gives the Czech Republic a unique position on the global stage.
H2 Longevity® Center in Ostrava
Building on successful scientific research, the H2 Longevity® Center was recently opened in Ostrava. This next-generation center combines molecular hydrogen inhalation using H2 Medical Technologies devices, light therapy, hydrogen hydration through H2 Premium Hydrogen Water, specialized hydrogen dietary supplements, and education on regeneration and healthy longevity. The center functions as a showroom for distributors, investors, and partners, as well as for customers. The group plans to use the acquired know-how to build a network of partner H2 Longevity® concepts in other cities and countries.
A Strategic Global Partner with a Unique Hydrogen Solution
A major part of the business also involves collaboration with partners seeking to launch their own premium hydrogen-based longevity product lines. Interest is coming from various countries across Europe and beyond. These include medical centers, wellness hotels, private clinics, and other facilities focused on biohacking, longevity, body care, and overall regeneration. Partners appreciate the option to create their own premium brand as well as the ability to leverage the company’s existing portfolio. H2 Global Group thus acts as a strategic global partner—not just a manufacturer, but a leader of the entire segment—setting the direction for hydrogen technologies while supporting brand building and the growth of its distribution partners.
Hydrogen as a Pillar of Longevity
The group offers partners the opportunity to build a comprehensive system of hydrogen-based care with emphasis on maximum safety and therapeutic efficacy. The system includes professional training on installation, handling, and use of molecular hydrogen inhalation devices; proven procedures and protocols; incorporation of hydrogen water into hydration routines; and hydrogen dietary supplements to enhance therapy outcomes. Technical support, including warranty and post-warranty service, is guaranteed. The modular and scalable system can be tailored to clients’ needs and local market specifics, while drawing on scientific and practical knowledge and accumulated experience.
Opportunities for Service Providers, Distributors, and Investors
For partners in healthcare, wellness, spa, and cosmetics, H2 Global Group represents an opportunity to participate in creating a new standard in the rapidly growing longevity segment. This includes local hydrogen zones in clinics, hotels, wellness centers, and spas, as well as complete portfolios of functional hydrogen products under a private label. For investors, the combination of proprietary medical research and development, international patent protection, existing clinical evidence in molecular hydrogen use, global scalability through exclusive partnerships and licensing models, and the strong trend toward longevity, prevention, and health optimization makes for an attractive proposition.
H2 Global Group is expanding its partner network and entering key foreign markets. It is opening cooperation opportunities for investors and strategic partners who want to be part of building a modern global longevity infrastructure using a proven and effective tool for achieving the best possible outcomes. If you wish to include cutting-edge hydrogen technologies in your portfolio and build a strong and respected brand using the best the market has to offer—while participating in the growth of an exceptionally promising global segment—now is the right moment to join.
The report is available to the public on the website here:
- protext.cz
- barrandov.tv
- buzzstore.cz
- ceskenoviny.cz
- cesko247.cz
- ekonews.cz
- finmag.cz
- hrot24.cz
- i60.cz
- i-lifestyle.cz
- media24.cz
- medialive.cz
- mediatoday.cz
- metro.cz
- newsradar.cz
- protext.sk
- svethospodarstvi.cz
- wn24.cz
- zpravyted.cz
Company Contact: H2 Global Group
www.H2global.group
www.H2Vibe.cz
www.H2invest.cz
Source: H2 Global Group
ČTK Connect provides an image attachment available at https://www.protext.cz.
PROTEXT